Project AFECT (Autism Family Empowerment Coaching and Training Program)
AFECT
Autism Family Empowerment Coaching and Training Program (AFECT): Evaluating a Parent Coaching and Family Navigation Program for New Autism Spectrum Disorder Diagnosis
1 other identifier
interventional
143
1 country
2
Brief Summary
The goal of this clinical trial is to learn about the journey of families after their child's diagnosis of autism and to help parents understand autism and get the right treatments for their child. This study is for parents of children just diagnosed with autism who are:
- Age greater than 1 and up to 5 years old;
- Hispanic/Latino OR Black/African-American OR have Medi-Cal as primary health insurance; AND
- Live in one of the following counties in California (Alameda, Contra Costa, Marin, Monterey, Napa, San Benito, San Francisco, San Mateo, Santa Clara, Santa Cruz, Solano, or Sonoma). The main questions it aims to answer are:
- Whether parent coaching through Project AFECT leads to decreased parental stress and increased parental confidence;
- Whether family navigation through Project AFECT leads to increased number of referrals to early intervention and educational services and reduced wait times to autism treatments;
- Whether children whose parents receive Project AFECT intervention show increased language skills compared to children whose parents did not receive intervention. Participants will be asked to:
- Complete surveys at enrollment and 3 and 6 months later.
- Work with Project AFECT Coach. Researchers will compare control and intervention groups to see if Project AFECT leads to improved parent and child outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2023
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2023
CompletedFirst Posted
Study publicly available on registry
June 18, 2023
CompletedStudy Start
First participant enrolled
September 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2025
CompletedSeptember 17, 2026
September 1, 2026
2.2 years
June 9, 2023
September 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Self-Efficacy
Mean change from baseline in parental self-efficacy measured using Autism-Specific Parenting Self-Efficacy Scale (PSEaS). Overall possible scores on the scale range from 17 - 85. The higher the score, the higher the measured level of parental self-efficacy (better outcome).
From enrollment to the end of intervention at 6 months
Stress Level
Mean change from baseline in parental stress level measured using Parental Stress Scale (PSS). Overall possible scores on the scale range from 18 - 90. The higher the score, the higher the measured level of parental stress (worse outcome).
From enrollment to the end of intervention at 6 months
Secondary Outcomes (3)
Child's Language Development
From enrollment to the end of intervention at 6 months
Access to autism treatments
From enrollment to the end of intervention at 6 months
Access to early intervention/special education
From enrollment to the end of intervention at 6 months
Study Arms (1)
Coaching Group
EXPERIMENTALCoaching Group will receive Project AFECT intervention, in addition to treatment as usual.
Interventions
Participants in the intervention group will be connected with Project AFECT Coaches who will provide: Coaching to (1) assure parents understand diagnosis, (2) assist parents in finding accurate, current information about autism, (3) guide parents to free online autism training resources, (4) empower parents to evaluate child's intervention plan holistically, and (5) provide emotional support to reduce stress; Navigation to (1) help family access autism treatments, and (2) connect to early intervention and educational services.
Eligibility Criteria
You may qualify if:
- \. Parents of children just diagnosed with autism (with or without other diagnoses) who are:
- Age greater than 1 and up to 5 years old;
- Hispanic/Latino OR Black/African-American OR have Medi-Cal as primary health insurance; AND
- Live in one of the following counties in California (Alameda, Contra Costa, Marin, Monterey, Napa, San Benito, San Francisco, San Mateo, Santa Clara, Santa Cruz, Solano, or Sonoma).
You may not qualify if:
- Non-legal guardians or foster parents who provide care to children newly diagnosed with autism.
- Parents of children without diagnosis of autism.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Gardner Packard Children's Health Center
Atherton, California, 94027, United States
Stanford Medicine Children's Health
Sunnyvale, California, 94087, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heidi Feldman, MD, PhD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Developmental and Behavioral Pediatrics, Stanford University School of Medicine
Study Record Dates
First Submitted
June 9, 2023
First Posted
June 18, 2023
Study Start
September 19, 2023
Primary Completion
December 12, 2025
Study Completion
December 12, 2025
Last Updated
September 17, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared with other researchers. This study collects sensitive self-reported data on parental stress, family functioning, and child characteristics, which are inherently personal in nature. Participants were not consented for broader data sharing beyond the purposes of this specific research project, making IPD sharing inconsistent with the informed consent agreements under which data were collected. Aggregate results and findings will be made available through peer-reviewed publication.